ROCKLAND, Mass.--(BUSINESS WIRE)--BioSphere Medical, Inc. (NASDAQ: BSMD), the medical device company that pioneered the use of bioengineered microspheres to treat uterine fibroids, hypervascularized tumors and vascular malformations by a procedure called embolization, announced today that it plans to issue financial results for the third quarter ended September 30, 2006 on November 2, 2006 before the market opens. Management will conduct a conference call that morning at 10:00 a.m. Eastern Time (9:00 a.m. Central Time) to discuss these results.
